Clinical Trials
2 trialsNCT02953509 2025-05-29
Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Gilead Sciences
Phase 1/2 Terminated
NCT00607152 2014-05-08
Rasburicase (Fasturtec) Registration Trial
Sanofi
Phase 3 Terminated